Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Date:4/20/2011

e,” “plan,” “estimate,” “intend” and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding our expected net sales, GAAP earnings and adjusted earnings for the second quarter and full year 2011, including expected impacts of acquisitions and the Neurovascular divestiture; our financial performance; the market for our products, including the U.S. CRM market; regulatory compliance; clinical trial results; new product introductions and the market acceptance of those products; our market position; our presence in emerging markets; the strength of our balance sheet; write-down of goodwill and other asset impairments; our capacity to generate sufficient cash flow to fund acquisitions and other investments, and our ability to successfully integrate them into our business; our ability to successfully separate our Neurovascular business; our ability to reduce our debt obligations; our ability to achieve aspirational goals, including near-term EPS growth; our ability to execute our POWER strategy; and our restructuring activities.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Risks and uncertainties that may c
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
2. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
3. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
4. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
5. Boston Scientific Announces Its ACC 2011 Schedule
6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
7. Boston Scientific to Webcast Analyst Event
8. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
9. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
10. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
11. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 Research and ... of the "Prescription Pain Drugs - Including ... - Global Markets, Competitors and Opportunities: 2015 - ... offering. Pain is defined as ... actual or potential tissue damage. At some point, ...
(Date:8/29/2015)... 29, 2015 La sofisticada ... los sistemas de imagen por Ultrasonidos   ofrece resultados ... examen rápidos y un flujo de trabajo   optimizado, ... el proceso de detección de Cardiopatías   ... hoy el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 28, 2015 ... therapeutics for the treatment of cancer, today announced the ... the U.S. Securities and Exchange Commission (SEC) relating to ... The number of shares to be offered and the ... determined. CytomX intends to list its common stock under ...
Breaking Medicine Technology:Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5CytomX Files Registration Statement for Proposed Initial Public Offering 2
(Date:8/31/2015)... , ... September 01, 2015 , ... The PT Outcomes ... clinically relevant measures for physical therapy patients. The Registry is being developed by the ... Inc. stated "We are happy to be selected to contribute FOTO Outcomes measures as ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... released their latest predictive use case focused on helping hospital perform under the ... this program, hospital payments are adjusted based on performance across four domains related ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... in giving potential patients the resources they need to have a successful cosmetic ... board certified plastic surgeons; Cosmetic Town Journal is always ready to help. , ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Western University of Health Sciences to learn more about its integrated approach ... of Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan ...
(Date:8/31/2015)... ... ... to undergoing a hair transplant, most patients have donor hair moved from one part of ... on top of the scalp, as well as filling in areas missing hair, is a ... areas of their head. , What about patients who have a limited, or even depleted, ...
Breaking Medicine News(10 mins):Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2
... PARK, Ill., March 4 Abbott will present at ... on Tuesday, March 17. Thomas C. Freyman, executive ... a formal presentation on the company at 8:30 a.m. ... be accessible through Abbott,s Investor Relations Web site at ...
... BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader ... today announced that on or before March 16, 2009 ... for the Southern District of New York, its response ... investors, Longview Special Finance, Inc. and Longview Fund, L.P. ...
... , , WEDNESDAY, March 4 (HealthDay News) -- Scientists report ... HIV-like virus in five female monkeys, an encouraging sign ... research is still in its early stages. However, the ... into sexual lubricants that women could use to avoid ...
... Verathon(R) is pleased to announce the new BladderScan(R) ... to help physicians identify the presence of abdominal ... the BladderScan(R) BVI 9000 series will make its ... in Rosemont, IL on March 5. (Verathon Booth ...
... (NYSE: CVS ) today announced that its ... $0.07625 per share on the Common Stock of the ... on April 22, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )About CVS ... the nation. The Company fills or manages more than ...
... 04, 2009 A new study appearing in Journal ... women who reported taking daily naps had a significantly greater ... contrast to a number of prior studies which have indicated ... 8,101 Caucasian women aged 69 and older were studied over ...
Cached Medicine News:Health News:BIO-key to Respond in Court to a Lawsuit Filed by Two Investors 2Health News:BIO-key to Respond in Court to a Lawsuit Filed by Two Investors 3Health News:Germicide Might Guard Against HIV Infection 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 3Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 4
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... only catheter of its kind, the ... collects real-time cardiac electrical information, translating ... With 64 electrodes, this unique tool ... than 3,000 points of electrical data ...
... The St. Jude Medical® Pacing System Analyzer ... solution for implantation testing, programming and interrogation ... as an easy-to-use accessory to the St. ... testing by obtaining measurements of intrinsic P- ...
Medicine Products: